COMMON STOCK |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Equity [Abstract] | |
| COMMON STOCK | 4. COMMON STOCK
On May 2, 2025 the Company entered into an equity financing agreement (“2025 Finance Agreement”) with an investor, pursuant to which the investor may purchase up to $3,000,000 worth of common stock (see Note 7).
On September 8, 2026 the Company entered into an equity financing agreement (“2026 Finance Agreement”) with the same investor, which provides for the purchase by the investor of up to $3,000,000 worth of common stock (see Note 7).
On September 8, 2026 the Company issued shares of common stock totaling $16,476 for equity commitment fees related to the 2026 Finance Agreement. These shares were valued at a market price of $. These shares were recorded as a deferred offering cost (see Note 2).
During the nine months ended September 30, 2026 the Company issued an aggregate of shares of common stock for $836,593 under the 2025 Finance Agreement at prices ranging from $-$, pursuant to put notices sent to the investor. Finance costs of $7,766 were deducted from the gross proceeds, leaving net proceeds of $828,827 (see Note 2).
On May 2, 2025 the Company issued shares of common stock at a price of $ for a total of $30,000 for equity commitment fees related to the 2025 Finance Agreement.
During the nine months ended September 30, 2025 the Company issued an aggregate of shares of common stock for $639,027 under the 2025 Finance Agreement at prices ranging from $-$, pursuant to put notices sent to the investor. Finance costs of $23,582 were deducted from the gross proceeds, leaving net proceeds of $615,445 (see Note 2).
As of September 30, 2026 and December 31, 2025 and shares were outstanding, respectively.
|